Terbinafine
Terbinafine

3.12
A clinical formulation indicated for Antifungals. Precise action disrupts fungal cellular growth to assist in resolving persistent skin and nail infections.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Terbinafine
Reference Brand
Lamisil
Product Origin
Generic Product
Reference Manufacturer
Various generic manufacturers
Product Form
Tablet, Cream
Regulatory Classification
Rx
Primary Category
Infection Treatment, Skin Care
Product Category
Antifungal
Pharmacological Class
Antifungal
Manufacturer Description
A potent antifungal agent utilized to manage stubborn nail and skin fungal infections and designed to alleviate itching and target complete organism clearance.
Mechanism of Action
It inhibits the enzyme squalene epoxidase in the fungal cell. This stops the production of ergosterol and leads to an accumulation of toxic squalene.
Route of Administration
Oral
Onset Time
Weeks
Duration
6–12 weeks (nails)
Contraindications
Chronic or active liver disease, Severe kidney disease, Allergy to terbinafine
Severe Adverse Events
Liver failure, Severe blood count changes, Severe skin reactions (SJS), Vision changes
Common Side Effects
Nausea, Abdominal pain, Headache
Uncommon Side Effects
Taste disturbance, Diarrhea, Skin rash, Loss of appetite, Gas
Drug Interactions
Warfarin, Cimetidine, Rifampin, Cyclosporine, Caffeine
Pregnancy Safety Warnings
Not recommended during pregnancy.
Age Restrictions
Approved for children 4 years and older.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Information for Terbinafine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories